scholarly journals A Review of Assumed and Reported Intracluster Correlations in Cluster Randomized Trials

2019 ◽  
Author(s):  
Xiaoran Han ◽  
Jiaye Lin ◽  
Jinjing Xu ◽  
Maggie Wang ◽  
Benny Zee ◽  
...  

Abstract Background Cluster randomized trials (CRTs) are widely adopted in health and primary care research. However, the cluster effect needs to be taken into account appropriately in the design and analysis of CRTs. The objectives of this study were (i) to review the reporting of intracluster correlations in CRTs; and (ii) to evaluate whether the assumed intracluster correlation measures in sample size planning are consistent with those obtained in the analysis. Methods The Aggregate Analysis of ClinicalTrials.gov database was searched to identify CRTs registered between January 1, 2004 and March 27, 2016. The selected CRTs with accessible publications were screened according to eligibility criteria. Results Of the 281 CRTs identified, the percentage of studies accounting for cluster effect increased annually. A total of 183 studies accounted for clustering in sample size estimation, among them 43% of CRTs adopted the intraclass correlation coefficient (ICC) but the exact estimated value of ICC was provided in only 26% of the included studies. In different intervention types, there were no statistically significant differences between the assumed and reported values of ICC (all p-values >0.05). Conclusion Although the difference between the values of ICC assumed in sample size planning and that reported in the analysis was not statistically significant, deficiencies in CRTs are still common, such as low rates of considering cluster effect in sample size and reporting intracluster correlation estimates. We also suggest that researchers ought to be familiar with the properties of statistical approaches to improve the analysis of CRTs. Thus, more recommendations and guidelines such as the CONSORT statement for CRTs should be suggested to researchers.

2020 ◽  
Vol 29 (9) ◽  
pp. 2470-2480
Author(s):  
Ariane M Mbekwe Yepnang ◽  
Agnès Caille ◽  
Sandra M Eldridge ◽  
Bruno Giraudeau

In cluster randomized trials, the intraclass correlation coefficient (ICC) is classically used to measure clustering. When the outcome is binary, the ICC is known to be associated with the prevalence of the outcome. This association challenges its interpretation and can be problematic for sample size calculation. To overcome these situations, Crespi et al. extended a coefficient named R, initially proposed by Rosner for ophthalmologic data, to cluster randomized trials. Crespi et al. asserted that R may be less influenced by the outcome prevalence than is the ICC, although the authors provided only empirical data to support their assertion. They also asserted that “the traditional ICC approach to sample size determination tends to overpower studies under many scenarios, calling for more clusters than truly required”, although they did not consider empirical power. The aim of this study was to investigate whether R could indeed be considered independent of the outcome prevalence. We also considered whether sample size calculation should be better based on the R coefficient or the ICC. Considering the particular case of 2 individuals per cluster, we theoretically demonstrated that R is not symmetrical around the 0.5 prevalence value. This in itself demonstrates the dependence of R on prevalence. We also conducted a simulation study to explore the case of both fixed and variable cluster sizes greater than 2. This simulation study demonstrated that R decreases when prevalence increases from 0 to 1. Both the analytical and simulation results demonstrate that R depends on the outcome prevalence. In terms of sample size calculation, we showed that an approach based on the ICC is preferable to an approach based on the R coefficient because with the former, the empirical power is closer to the nominal one. Hence, the R coefficient does not outperform the ICC for binary outcomes because it does not offer any advantage over the ICC.


2019 ◽  
Vol 18 (1) ◽  
Author(s):  
Pimnara Peerawaranun ◽  
Jordi Landier ◽  
Francois H. Nosten ◽  
Thuy-Nhien Nguyen ◽  
Tran Tinh Hien ◽  
...  

Abstract Background Sample size calculations for cluster randomized trials are a recognized methodological challenge for malaria research in pre-elimination settings. Positively correlated responses from the participants in the same cluster are a key feature in the estimated sample size required for a cluster randomized trial. The degree of correlation is measured by the intracluster correlation coefficient (ICC) where a higher coefficient suggests a closer correlation hence less heterogeneity within clusters but more heterogeneity between clusters. Methods Data on uPCR-detected Plasmodium falciparum and Plasmodium vivax infections from a recent cluster randomized trial which aimed at interrupting malaria transmission through mass drug administrations were used to calculate the ICCs for prevalence and incidence of Plasmodium infections. The trial was conducted in four countries in the Greater Mekong Subregion, Laos, Myanmar, Vietnam and Cambodia. Exact and simulation approaches were used to estimate ICC values for both the prevalence and the incidence of parasitaemia. In addition, the latent variable approach to estimate ICCs for the prevalence was utilized. Results The ICCs for prevalence ranged between 0.001 and 0.082 for all countries. The ICC from the combined 16 villages in the Greater Mekong Subregion were 0.26 and 0.21 for P. falciparum and P. vivax respectively. The ICCs for incidence of parasitaemia ranged between 0.002 and 0.075 for Myanmar, Cambodia and Vietnam. There were very high ICCs for incidence in the range of 0.701 to 0.806 in Laos during follow-up. Conclusion ICC estimates can help researchers when designing malaria cluster randomized trials. A high variability in ICCs and hence sample size requirements between study sites was observed. Realistic sample size estimates for cluster randomized malaria trials in the Greater Mekong Subregion have to assume high between cluster heterogeneity and ICCs. This work focused on uPCR-detected infections; there remains a need to develop more ICC references for trials designed around prevalence and incidence of clinical outcomes. Adequately powered trials are critical to estimate the benefit of interventions to malaria in a reliable and reproducible fashion. Trial registration: ClinicalTrials.govNCT01872702. Registered 7 June 2013. Retrospectively registered. https://clinicaltrials.gov/ct2/show/NCT01872702


2010 ◽  
Vol 8 (1) ◽  
pp. 27-36 ◽  
Author(s):  
Zhiying You ◽  
O Dale Williams ◽  
Inmaculada Aban ◽  
Edmond Kato Kabagambe ◽  
Hemant K Tiwari ◽  
...  

2021 ◽  
pp. 096228022199041
Author(s):  
Fan Li ◽  
Guangyu Tong

The modified Poisson regression coupled with a robust sandwich variance has become a viable alternative to log-binomial regression for estimating the marginal relative risk in cluster randomized trials. However, a corresponding sample size formula for relative risk regression via the modified Poisson model is currently not available for cluster randomized trials. Through analytical derivations, we show that there is no loss of asymptotic efficiency for estimating the marginal relative risk via the modified Poisson regression relative to the log-binomial regression. This finding holds both under the independence working correlation and under the exchangeable working correlation provided a simple modification is used to obtain the consistent intraclass correlation coefficient estimate. Therefore, the sample size formulas developed for log-binomial regression naturally apply to the modified Poisson regression in cluster randomized trials. We further extend the sample size formulas to accommodate variable cluster sizes. An extensive Monte Carlo simulation study is carried out to validate the proposed formulas. We find that the proposed formulas have satisfactory performance across a range of cluster size variability, as long as suitable finite-sample corrections are applied to the sandwich variance estimator and the number of clusters is at least 10. Our findings also suggest that the sample size estimate under the exchangeable working correlation is more robust to cluster size variability, and recommend the use of an exchangeable working correlation over an independence working correlation for both design and analysis. The proposed sample size formulas are illustrated using the Stop Colorectal Cancer (STOP CRC) trial.


2020 ◽  
Vol 45 (4) ◽  
pp. 446-474
Author(s):  
Zuchao Shen ◽  
Benjamin Kelcey

Conventional optimal design frameworks consider a narrow range of sampling cost structures that thereby constrict their capacity to identify the most powerful and efficient designs. We relax several constraints of previous optimal design frameworks by allowing for variable sampling costs in cluster-randomized trials. The proposed framework introduces additional design considerations and has the potential to identify designs with more statistical power, even when some parameters are constrained due to immutable practical concerns. The results also suggest that the gains in efficiency introduced through the expanded framework are fairly robust to misspecifications of the expanded cost structure and concomitant design parameters (e.g., intraclass correlation coefficient). The proposed framework is implemented in the R package odr.


Sign in / Sign up

Export Citation Format

Share Document